NewsBenzingaOppenheimer Reiterates Outperform on Tyra Biosciences, Lowers Price Target to $40 Oppenheimer Reiterates Outperform on Tyra Biosciences, Lowers Price Target to $40 Benzinga 2026.09.22 17:10 (GMT+0) Open on Benzinga Other news HSBC Downgrades Netflix to Hold, Lowers Price Target to $76 Stephens & Co. Maintains Equal-Weight on Cal-Maine Foods, Lowers Price Target to $80 Bitcoin Cash, Uniswap Surges as CME Announces New Futures Contracts: What's Going On? A CEO Shakeup Just Tanked This Stock. How to Play It Here. Twilio Stock Jumps As Analysts See AI Agents Dialing Up Growth HC Wainwright & Co. Maintains Buy on Anixa Biosciences, Lowers Price Target to $6
